JPS6310696B2 - - Google Patents

Info

Publication number
JPS6310696B2
JPS6310696B2 JP54095152A JP9515279A JPS6310696B2 JP S6310696 B2 JPS6310696 B2 JP S6310696B2 JP 54095152 A JP54095152 A JP 54095152A JP 9515279 A JP9515279 A JP 9515279A JP S6310696 B2 JPS6310696 B2 JP S6310696B2
Authority
JP
Japan
Prior art keywords
group
indanyl
compound according
methanesulfonamide
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54095152A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5520777A (en
Inventor
Shureedaa Eruberuharuto
Ruufueru Kuremensu
Betsutohieru Irumugaruto
Furiidoritsuhi Katsupu Yoahimu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS5520777A publication Critical patent/JPS5520777A/ja
Publication of JPS6310696B2 publication Critical patent/JPS6310696B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/38—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. nitrodiphenyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9515279A 1978-07-27 1979-07-27 Novel indanyl derivative*its manufacture and remedy containing it for inflammatory disease Granted JPS5520777A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782833202 DE2833202A1 (de) 1978-07-27 1978-07-27 Neue indanyl- und tetralinylamide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
JPS5520777A JPS5520777A (en) 1980-02-14
JPS6310696B2 true JPS6310696B2 (de) 1988-03-08

Family

ID=6045651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9515279A Granted JPS5520777A (en) 1978-07-27 1979-07-27 Novel indanyl derivative*its manufacture and remedy containing it for inflammatory disease

Country Status (5)

Country Link
JP (1) JPS5520777A (de)
DE (1) DE2833202A1 (de)
HU (1) HU184679B (de)
SU (1) SU965352A3 (de)
ZA (1) ZA793854B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504310A (ja) * 1988-05-09 1991-09-19 ケイ・エイチ・テクノロジー・コーポレイション ラウドスピーカー

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86462A (en) * 1987-05-29 1992-12-01 Fujisawa Pharmaceutical Co Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504310A (ja) * 1988-05-09 1991-09-19 ケイ・エイチ・テクノロジー・コーポレイション ラウドスピーカー

Also Published As

Publication number Publication date
JPS5520777A (en) 1980-02-14
SU965352A3 (ru) 1982-10-07
HU184679B (en) 1984-09-28
DE2833202A1 (de) 1980-02-14
ZA793854B (en) 1980-07-30

Similar Documents

Publication Publication Date Title
EP0009554B1 (de) Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
JPH049783B2 (de)
FR2621585A1 (fr) Derives de 4h-benzopyranne-1 one-4 et leurs sels, leurs procedes de fabrication et compositions pharmaceutiques les comprenant en tant qu'ingredients actifs
US3642785A (en) Indenyl-3-aliphatic amines
JPS6247176B2 (de)
EP0317332A2 (de) Sulfonanilidverbindungen
JPH08500585A (ja) 新規のロイコトリエン−ｂ▲下４▼−アンタゴニスト、その製造方法およびその医薬としての使用
JPH06135934A (ja) ピリジン誘導体又はその塩を含有するホスホリパーゼ▲ａ２▼阻害剤、抗炎症剤又は抗膵炎剤
JPH0150698B2 (de)
JPS6310696B2 (de)
JPS6366135A (ja) 血小板活性化因子▲きつ▼抗薬としての新規１，３−ジアリ−ルシクロペンタン及びその誘導体
SU900808A3 (ru) Способ получени аминопропанолпроизводных 6-окси-2,3,4,5-тетрагидро-1н-1-бензазепин-2-она или их солей
JPS623145B2 (de)
JPS5849369A (ja) 新規のイミダゾール化合物
EP0184809B1 (de) Imidazolylalkoxyindanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
JPS5840544B2 (ja) １−（２−（ｂ− ナフチルオキシ ）−エチル）−３− メチル − ピラゾロン −（５） ノセイゾウホウホウ
JPH0662547B2 (ja) グリシン誘導体
CA2089728A1 (en) Pyridylthio or pyridyloxy alkanoic acids
DE2756771A1 (de) Verfahren zur herstellung von neuen substituierten 5-amino-2-pyridincarbonsaeure-verbindungen
JPH0250906B2 (de)
DE2923937A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
US5371284A (en) Phenyl acetylenic acetals
HUT71887A (en) Process for producing pyridine derivatives as leucotriene b4 antagonists
US3923859A (en) Substituted fulvene acetic acids and derivatives
JPS61180761A (ja) ６−置換アズレン誘導体スルホン酸塩，抗潰瘍剤及びその製造方法